Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT00878254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Mantle-Cell Lymphoma

Interventions

BIOLOGICAL: G-CSF
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Leucovorin
DRUG: Mesna
DRUG: Methotrexate
DRUG: Vincristine

Sponsor

University of Miami